Inari Medical Stock News

Inari Medical, Inc. (NASDAQ:NARI) CFO Mitch C. Hill sold 20,000 shares of Inari Medical stock in a transaction dated Wednesday, December 15th. The stock was sold at an average price of $79.04, for a total value of $1,580,800.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through the []

DarioHealth (NASDAQ:DRIO) and Inari Medical (NASDAQ:NARI) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk. Earnings & Valuation This table compares DarioHealth and Inari Medicals gross revenue, earnings per share and valuation. []

Inari Medical (NASDAQ:NARI) and DarioHealth (NASDAQ:DRIO) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk. Earnings & Valuation This table compares Inari Medical and DarioHealths revenue, earnings per share and valuation. Gross []

Huge gains could be up ahead if the rest of the market sees these stocks in the same light as investment bank analysts.

Huge gains could be up ahead if the rest of the market sees these stocks in the same light as investment bank analysts.

Inari Medical, Inc. (NASDAQ:NARI) CEO William Hoffman sold 60,000 shares of the stock in a transaction that occurred on Monday, December 6th. The shares were sold at an average price of $78.63, for a total transaction of $4,717,800.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available []

Our Foolish roundtable has three stocks to invest in as we enter our third year of the COVID pandemic.

Our Foolish roundtable has three stocks to invest in as we enter our third year of the COVID pandemic.

Related Stocks: NARI ,

Inari Medical, Inc. (NASDAQ:NARI) saw a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 1,110,000 shares, a decline of 26.0% from the October 31st total of 1,500,000 shares. Based on an average trading volume of 491,500 shares, the short-interest ratio is currently 2.3 days. []

Shares of Inari Medical, Inc. (NASDAQ:NARI) have been given an average rating of Buy by the six ratings firms that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell rating and five have issued a buy rating on the company. The average 1-year price target among analysts that []

BTIG Research restated their buy rating on shares of Inari Medical (NASDAQ:NARI) in a research report report published on Monday morning, Price Targets.com reports. BTIG Research currently has a $139.00 target price on the stock. A number of other analysts also recently issued reports on NARI. SVB Leerink lifted their price objective on shares of []

It doesn't take a lot to own a piece of these rapidly growing healthcare businesses.

Prudential Financial Inc. trimmed its holdings in Inari Medical, Inc. (NASDAQ:NARI) by 82.2% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 6,192 shares of the companys stock after selling 28,661 shares during the period. Prudential Financial Inc.s holdings in Inari Medical were worth $578,000 as of its most recent filing with the Securities []